AU633714B2 - New uses of l-deprenyl and compositions for same - Google Patents

New uses of l-deprenyl and compositions for same

Info

Publication number
AU633714B2
AU633714B2 AU73957/91A AU7395791A AU633714B2 AU 633714 B2 AU633714 B2 AU 633714B2 AU 73957/91 A AU73957/91 A AU 73957/91A AU 7395791 A AU7395791 A AU 7395791A AU 633714 B2 AU633714 B2 AU 633714B2
Authority
AU
Australia
Prior art keywords
deprenyl
compositions
same
new uses
frequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU73957/91A
Other languages
English (en)
Other versions
AU7395791A (en
Inventor
Gwendolyn O. Ivy
Norton W. Milgram
David R. Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deprenyl Animal Health Inc
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27076843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU633714(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/576,011 external-priority patent/US5151449A/en
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Publication of AU7395791A publication Critical patent/AU7395791A/en
Application granted granted Critical
Publication of AU633714B2 publication Critical patent/AU633714B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thin Film Transistor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Rotary Switch, Piano Key Switch, And Lever Switch (AREA)
  • Pulse Circuits (AREA)
  • Electrotherapy Devices (AREA)
AU73957/91A 1990-08-31 1991-03-28 New uses of l-deprenyl and compositions for same Ceased AU633714B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/576,011 US5151449A (en) 1990-08-31 1990-08-31 Use of L-deprenyl for retention of specific physiological functions
US576011 1990-08-31
US64345291A 1991-01-18 1991-01-18
US643452 1991-01-18

Publications (2)

Publication Number Publication Date
AU7395791A AU7395791A (en) 1992-03-05
AU633714B2 true AU633714B2 (en) 1993-02-04

Family

ID=27076843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73957/91A Ceased AU633714B2 (en) 1990-08-31 1991-03-28 New uses of l-deprenyl and compositions for same

Country Status (16)

Country Link
US (2) US5276057A (es)
EP (2) EP0473252B1 (es)
JP (3) JP2819072B2 (es)
AT (2) ATE181501T1 (es)
AU (1) AU633714B2 (es)
BR (1) BR9103506A (es)
CA (1) CA2039194C (es)
DE (2) DE69131386T2 (es)
DK (2) DK0473252T3 (es)
ES (2) ES2135123T3 (es)
GR (2) GR3022971T3 (es)
HK (1) HK1011611A1 (es)
ID (1) ID19492A (es)
MX (1) MX9100067A (es)
MY (2) MY110217A (es)
NZ (1) NZ238277A (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (en) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
EP0623344B1 (fr) * 1993-05-04 2000-07-26 Ceva Sante Animale Utilisation de la Sélégiline en médecine vetérinaire
CN100360123C (zh) 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
JPH10513455A (ja) * 1995-02-10 1998-12-22 ザ ユニバーシティ オブ トロント イノベーションズ ファウンデーション 緑内障治療用のデプレニル化合物
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JPH11506744A (ja) 1995-06-07 1999-06-15 ノウブン ファーマシューティカルズ インク． 室温で液体である低分子量薬を含む経皮組成物
CN1207675A (zh) * 1995-11-06 1999-02-10 萨默塞特药品有限公司 丙炔苯丙胺的经颊和舌下给药法
BR9908713A (pt) 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
US20030212144A1 (en) * 2001-07-18 2003-11-13 Mohankumar Sheba J.J. Method for inducing an estrous cycle and pregnancy in a female mammal
CA2505476C (en) * 2002-11-07 2015-05-26 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
EP1622450A4 (en) * 2003-04-25 2009-11-18 Endo Pharmaceuticals Solutions PROCESS FOR PROMOTING UNINTERRUPTED SLEEP BY ADMINISTERING TROPIUM CHLORIDE
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
CA2547053C (en) 2003-11-25 2014-05-27 Technion Research & Development Foundation Ltd. Compositions and methods for treatment of cardiovascular disorders and diseases
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
EP2519115B1 (en) 2009-12-29 2017-02-15 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
TR201909277T4 (tr) 2010-02-03 2019-07-22 Pharma Two B Ltd Rasajilinin genişletilmiş salınım formülasyonları ve kullanım alanları.
CN103860503A (zh) * 2012-12-10 2014-06-18 天津市汉康医药生物技术有限公司 一种治疗帕金森病的缓释药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4880883A (en) * 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)

Also Published As

Publication number Publication date
NZ238277A (en) 1993-10-26
JPH09328422A (ja) 1997-12-22
CA2039194A1 (en) 1992-03-01
ES2135123T3 (es) 1999-10-16
DE69131386D1 (de) 1999-07-29
MY110217A (en) 1998-03-31
JP2819072B2 (ja) 1998-10-30
JPH09328423A (ja) 1997-12-22
ATE181501T1 (de) 1999-07-15
JP2884500B2 (ja) 1999-04-19
DK0473252T3 (da) 1997-09-15
US5387615A (en) 1995-02-07
GR3031263T3 (en) 1999-12-31
MX9100067A (es) 1992-04-01
HK1011611A1 (en) 1999-07-16
EP0473252A2 (en) 1992-03-04
EP0732101B1 (en) 1999-06-23
JP2884501B2 (ja) 1999-04-19
EP0473252A3 (en) 1992-08-05
DE69124875T2 (de) 1997-06-26
AU7395791A (en) 1992-03-05
ATE149350T1 (de) 1997-03-15
EP0473252B1 (en) 1997-03-05
US5276057A (en) 1994-01-04
ES2097790T3 (es) 1997-04-16
MY124210A (en) 2006-06-30
EP0732101A1 (en) 1996-09-18
DK0732101T3 (da) 1999-11-22
DE69131386T2 (de) 1999-11-25
JPH04230624A (ja) 1992-08-19
BR9103506A (pt) 1992-05-12
ID19492A (id) 1998-07-16
GR3022971T3 (en) 1997-06-30
CA2039194C (en) 1997-01-28
DE69124875D1 (de) 1997-04-10

Similar Documents

Publication Publication Date Title
AU633714B2 (en) New uses of l-deprenyl and compositions for same
ZA895936B (en) Pharmaceutical compositions comprising selected lactobacillus strains
NO902834D0 (no) Regulering av mikrobiell vekst med lantibiotiske/lysosymformuleringer.
ES2022443B3 (es) Utilizacion fungicida de un derivado de cianopirrol.
NO895186D0 (no) Regulering av mikrobiell vekst med nisin/lysosym formuleringer.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
DE3851456D1 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
IT8919975A0 (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
EP0351876A3 (en) Composition for potentiating vaccination effect
DK0550783T3 (da) Anvendelse af diolestere i hunde- og kattefoder
FR2636239B1 (fr) Composition desinfectante pour la prevention de la mammite subclinique chez les ruminants
AU2492892A (en) The device for treatment and prophylaxis of mastitis in animals
NZ222855A (en) Bacterial composition used as an animal treatment
ZA911347B (en) Compositions and methods for treating infections caused by organisms sensitive to"-lactam antibiotics
RU96108586A (ru) Способ приготовления премикса
IT1232796B (it) Composizioni sinergisticamente attive e procedimento per la loro preparazione.
IT1251993B (it) Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico
IT8921302A0 (it) Composizione conservabile per l'alimentazione di giovani mammiferi e procedimento per la sua preparazione.